|
Subsequent Events (Details Textual) (USD $)
|
0 Months Ended | 12 Months Ended | 24 Months Ended | 1 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Oct. 15, 2009
|
Jan. 31, 2008
|
Dec. 31, 2013
|
Jun. 30, 2008
|
Dec. 31, 2012
|
Jun. 30, 2011
|
Dec. 31, 2013
Exercise Price One [Member]
|
Dec. 31, 2013
Exercise Price Two [Member]
|
Jan. 28, 2014
Subsequent Event [Member]
|
Dec. 31, 2013
Subsequent Event [Member]
|
Jan. 28, 2014
Subsequent Event [Member]
Exercise Price One [Member]
|
Jan. 28, 2014
Subsequent Event [Member]
Exercise Price Two [Member]
|
Jan. 28, 2014
Subsequent Event [Member]
Maximum [Member]
|
Jan. 28, 2014
Subsequent Event [Member]
Minimum [Member]
|
Jan. 28, 2014
Subsequent Event [Member]
Private Placement [Member]
|
Dec. 31, 2013
Subsequent Event [Member]
Private Placement [Member]
|
Dec. 31, 2013
Subsequent Event [Member]
Private Placement [Member]
Feb 10, 2014 Warrants [Member]
|
Dec. 31, 2013
Subsequent Event [Member]
Private Placement [Member]
Mar 2, 2014 Warrants [Member]
|
Dec. 31, 2013
Subsequent Event [Member]
Private Placement [Member]
Apr 6, 2014 Warrants [Member]
|
Dec. 31, 2013
Dr Mullinix [Member]
|
Jul. 01, 2014
Dr Mullinix [Member]
Subsequent Event [Member]
|
Jan. 31, 2014
Dr Mullinix [Member]
Subsequent Event [Member]
|
Jan. 28, 2015
Consulting Agreement [Member]
Subsequent Event [Member]
|
Jan. 28, 2014
Consulting Agreement [Member]
Subsequent Event [Member]
|
Dec. 31, 2013
Consulting Agreement [Member]
Subsequent Event [Member]
|
|
| Subsequent Event [Line Items] | |||||||||||||||||||||||||
| Consulting Fees | $ 25,000 | ||||||||||||||||||||||||
| Consulting Fees One | 12,500 | ||||||||||||||||||||||||
| Consulting Fees Two | 12,500 | ||||||||||||||||||||||||
| Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Gross | 4,000,000 | ||||||||||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | 78,617 | 596,400 | |||||||||||||||||||||||
| Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Weighted Average Grant Date Fair Value | $ 0.15 | $ 0.02 | $ 0.15 | $ 0.04 | $ 0.15 | ||||||||||||||||||||
| Share Based Compensation Arrangement By Share Based Payment Award Options Fair Value Charged To Operations | 375,000 | 75,000 | 41,334 | 134,420 | 298,200 | ||||||||||||||||||||
| Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants | $ 1,748,800 | $ 815,920 | $ 312,880 | $ 620,000 | |||||||||||||||||||||
| Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price | $ 0.843 | $ 0.876 | $ 0.98 | $ 0.50 | $ 0.50 | ||||||||||||||||||||
| Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate | 262.00% | 262.00% | |||||||||||||||||||||||
| Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate | 0.00% | 0.00% | |||||||||||||||||||||||
| Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | 1.51% | 1.51% | |||||||||||||||||||||||
| Exercise Price Reduction Percentage | 50.00% | ||||||||||||||||||||||||
| Exercise Price Before Reduction | $ 0.75 | $ 0.50 | |||||||||||||||||||||||
| Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term | 2 years 7 months 13 days | 77 days | 5 years | ||||||||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | 2,000,000 | 2,000,000 | |||||||||||||||||||||||
| Warrants Exercisable | 6,659,840 | 6,659,840 | 2,084,840 | 4,575,000 | 2,253,800 | 4,575,000 | |||||||||||||||||||